BioSpace News Archive

CRH Medical Corporation (the “Company”) (TSX: CRH) (NYSE American: CRHM), announces that it has received approval from the Toronto Stock Exchange (“TSX”) of its Notice of Intention to renew its existing Normal Course Issuer Bid (the “Bid”).

Mosquitoes are getting increasingly worse and attacking relief volunteers as the floods continue to stay stagnant

TORONTO, /PRNewswire/ -- Katexco Pharmaceuticals, a medical cannabis company developing innovative, orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases, today announced that the Company’s Co-founder, Director and Chairman, Professor Lawrence Steinman, presented his latest research

Galderma Laboratories, L.P., a global leader focused on medical solutions in skin health, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the use of Restylane Lyft®

NTP architect insists the FDA is misleading the public-Risk of Brain Tumors is Real

With winter just around the corner, many people are starting to prepare for how to best stay healthy and productive all season long.

Global award recognises most promising deeptech startups to date

According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023.

Funds Raised Help Send Kids with Muscle Disease to MDA Summer Camp